These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9823576

  • 41. FDA may allow more conditional drug approvals.
    J Am Vet Med Assoc; 2014 Nov 01; 245(9):992. PubMed ID: 25470840
    [No Abstract] [Full Text] [Related]

  • 42. The importance of animals.
    Sundlof SF.
    FDA Consum; 2004 Nov 01; 38(1):40. PubMed ID: 15032204
    [No Abstract] [Full Text] [Related]

  • 43. FDA approves first canine diet drug.
    Nolen RS.
    J Am Vet Med Assoc; 2007 Mar 01; 230(5):641-2. PubMed ID: 17380625
    [No Abstract] [Full Text] [Related]

  • 44. The FDA takes action against unapproved drugs.
    Meadows M.
    FDA Consum; 2007 Mar 01; 41(1):34-5. PubMed ID: 17342837
    [Abstract] [Full Text] [Related]

  • 45. Canadian and US drug approval times and safety considerations.
    Rawson NS, Kaitin KI.
    Ann Pharmacother; 2003 Oct 01; 37(10):1403-8. PubMed ID: 14519031
    [Abstract] [Full Text] [Related]

  • 46. FDA launches priority vouchers for neglected-disease drugs.
    Waltz E.
    Nat Biotechnol; 2008 Dec 01; 26(12):1315-6. PubMed ID: 19060849
    [No Abstract] [Full Text] [Related]

  • 47. Protease inhibitor approvals: will people be cut off drug? Followup studies proposal needs support.
    James JS.
    AIDS Treat News; 1996 Mar 01; (no 242):3. PubMed ID: 11363191
    [Abstract] [Full Text] [Related]

  • 48. Whatever happened to user fees and the FDA's promise to expedite new drug approvals?
    Gatty B.
    Hosp Formul; 1993 Jul 01; 28(7):656, 655. PubMed ID: 10127048
    [No Abstract] [Full Text] [Related]

  • 49. Takings issues in the approval of generic biologics.
    Yoo JC.
    Food Drug Law J; 2005 Jul 01; 60(1):33-43. PubMed ID: 15940853
    [No Abstract] [Full Text] [Related]

  • 50. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Sep 29; 73(189):56487-91. PubMed ID: 18985960
    [Abstract] [Full Text] [Related]

  • 51. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
    AIDS Alert; 2003 Jan 29; 18(1):10-1. PubMed ID: 12541998
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Issues in bringing new drugs to the market.
    Tracey WR.
    Science; 2005 Dec 02; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.